CYTOKINETICS INC
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
Business Address 350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Mailing Address 350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Phone (650) 624-3000
Fiscal Year End 1231
EIN 943291317
Financial Overview
FY2024
-$388.95M
Net Income
$1.54B
Total Liabilities
$243.86M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 20, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
Insider Trading
STRONG SELL 7 insiders
15 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.